http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021238549-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee33b0e3e7398cf6fc957eeee59d510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3e9ac1a8a54862039d2b7dbb9f323b0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
filingDate 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f918ee5735766fe08860ab86254881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a7ccad7aa01bb383fd41333c01bbb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_327443e22e6b89421aeabf513ed39a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39786771c58cadc103957d35f63de41e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c14cd5381aa35678710989232ad78dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_978d8cd8b5ed0bebe4d6190b4ee7b6d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29dd242fc29edc9a4dd2a0b567a17706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba688096ebfde6f734146dafe8bd33bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9793a01054c6b7768f6a9df80f533785
publicationDate 2021-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021238549-A1
titleOfInvention Use of memory lymphocyte population in liver cancer treatment
abstract Provided are a memory lymphocyte population, a culture medium, and a method for obtaining the memory lymphocyte population and a use of the same. The memory lymphocyte population contains at least one of the following marker molecules: leukocyte differentiation antigens CD3, CD4, CD8, CD16, CD56, CD62L and CD45RO.
priorityDate 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 35.